Close
Almac
Achema middle east

News

A Simple Guide to Cataract Surgery & How to Prepare

When your optician or medical doctor informs you that you have the beginnings of the formation of a cataract, either in one eye or indeed both, it can sometimes come as a shock, especially if you currently have absolutely...

Critical Medicines Act Proposed By EU To Boost Drug Access

A group involving 19 European Union member countries is pushing for steps to lessen the bloc’s dependence when it comes to Chinese imports as far as pharmaceutical ingredients are concerned, according to a paper dated May 2. This move comes...

EU Drug Regulation Proposal Sparks Pushback From Industry

The EU's drug regulations can get a major makeover soon. In a set of proposals, the European Commission looks to address numerous shortfalls troubling the $148 billion pharmaceutical industry. The proposed upgrades give out the most significant revisions across...

EU Proposes Drug Manufacturing Overhaul, Faces Pushback

The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws. The changes have gone on to cause controversy among the manufacturers, with some even opining that they might...

IVI Cholera Jab From Korea To Undergo Swedish Clinical Trial

The South Korea-based International Vaccine Institute- IVI has gone ahead with the clinical manufacturing of DuoChol, a new low-cost oral vaccine for cholera in capsule form. The development has received funding support from the Wellcome Trust as well as...

Alcami Completes Expansion of cGMP Biostorage Facility in Amherst, NH

Alcami Corp., a CDMO, has completed the Phase III expansion of its cGMP biostorage facility in Amherst, NH, creating a total of 160,000 ft² of ambient cGMP biostorage capacity with 21,000 pallet locations. It is now fully operational to...

Arranta Bio, MIT Partner to Develop Rapid Manufacturing of mRNA Therapeutics

Arranta Bio, part of Recipharm’s biologics business, has signed a contract with MIT to develop a continuous manufacturing technology for mRNA therapeutics. The contract is part of the FDA’s initiative to have a fully integrated, continuous manufacturing production line...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »